Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
about
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccinesCharacterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in MiceNewcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Development and strategies of cell-culture technology for influenza vaccine.Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched VaccinesIncreased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Prior infection of chickens with H1N1 or H1N2 avian influenza elicits partial heterologous protection against highly pathogenic H5N1.Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines.Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferretA recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.DNA vaccination in the skin using microneedles improves protection against influenza.A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strainRoles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.
P2860
Q27013568-44DC349D-57FF-4399-8873-C57DE77E2884Q30375073-EC36DC13-E61F-48BB-AE4B-8C62435F43ABQ30382650-DBA54DDE-15C3-4B29-8B6D-DDF74CB6A22FQ30396047-69622C14-325B-49AB-937E-29D1E8DE93C0Q30396482-E202FEF7-2E05-4BB0-B3DA-2258D549631EQ30415387-549EE9F8-CECB-456D-B737-BDCD4353170CQ30424773-350FA0EA-547B-40D2-9D2B-45AA0B666765Q31088337-BC5BE24B-2306-4950-AE7F-C110C79353B1Q33547457-8F54A6A2-260F-48E1-B918-F4A689399BBDQ33815195-D834E677-464E-45CF-85DB-247F03BEC389Q34407701-02F64035-B355-413B-9BD4-9985C9EB2F0DQ34548282-2CFB6169-F7B8-457E-B286-7B2DBA450E6CQ35575511-0ABC479A-DAE1-41EE-96AC-5E5CAB0D11D8Q36085414-DF829C8E-EC76-49B4-B9BB-81BB00037E07Q36757868-8209ACF3-0C93-4EDC-BE98-5F062B6D890FQ37825824-56520B60-ACEE-41E5-ABDF-2E16272CDA76
P2860
Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@ast
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@en
type
label
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@ast
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@en
prefLabel
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@ast
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@en
P2093
P1433
P1476
Evaluation of conserved and va ...... rent isolates of H5N1 viruses.
@en
P2093
Kaylie Tran
Michael Gray
Xiaojian Yao
P304
P356
10.1016/J.VACCINE.2009.03.023
P407
P577
2009-04-01T00:00:00Z